BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17073807)

  • 1. Protein kinase CK2: a newcomer in the 'druggable kinome'.
    Pagano MA; Cesaro L; Meggio F; Pinna LA
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1303-6. PubMed ID: 17073807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase CK2 as a druggable target.
    Sarno S; Pinna LA
    Mol Biosyst; 2008 Sep; 4(9):889-94. PubMed ID: 18704226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A historical view of protein kinase CK2.
    Pinna LA
    Cell Mol Biol Res; 1994; 40(5-6):383-90. PubMed ID: 7735312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells.
    Vilk G; Weber JE; Turowec JP; Duncan JS; Wu C; Derksen DR; Zien P; Sarno S; Donella-Deana A; Lajoie G; Pinna LA; Li SS; Litchfield DW
    Cell Signal; 2008 Nov; 20(11):1942-51. PubMed ID: 18662771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.
    Franck N; Le Seyec J; Guguen-Guillouzo C; Erdtmann L
    J Virol; 2005 Mar; 79(5):2700-8. PubMed ID: 15708989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate.
    Yde CW; Ermakova I; Issinger OG; Niefind K
    J Mol Biol; 2005 Mar; 347(2):399-414. PubMed ID: 15740749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells.
    Salvi M; Xu D; Chen Y; Cabrelle A; Sarno S; Pinna LA
    Biochem Biophys Res Commun; 2009 Sep; 387(3):606-10. PubMed ID: 19616514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptide.
    Poletto G; Vilardell J; Marin O; Pagano MA; Cozza G; Sarno S; Falqués A; Itarte E; Pinna LA; Meggio F
    Biochemistry; 2008 Aug; 47(32):8317-25. PubMed ID: 18636746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Casein Kinase II: an attractive target for anti-cancer drug design.
    Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How druggable is protein kinase CK2?
    Cozza G; Bortolato A; Moro S
    Med Res Rev; 2010 May; 30(3):419-62. PubMed ID: 19526464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits.
    Salvi M; Sarno S; Marin O; Meggio F; Itarte E; Pinna LA
    FEBS Lett; 2006 Jul; 580(16):3948-52. PubMed ID: 16806200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level.
    Di Maira G; Brustolon F; Bertacchini J; Tosoni K; Marmiroli S; Pinna LA; Ruzzene M
    Oncogene; 2007 Oct; 26(48):6915-26. PubMed ID: 17486073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
    Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
    J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells.
    Franchin C; Cesaro L; Salvi M; Millioni R; Iori E; Cifani P; James P; Arrigoni G; Pinna L
    Biochim Biophys Acta; 2015 Jun; 1854(6):609-23. PubMed ID: 25278378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.
    Litchfield DW
    Biochem J; 2003 Jan; 369(Pt 1):1-15. PubMed ID: 12396231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different properties of four molecular forms of protein kinase CK2 from Saccharomyces cerevisiae.
    Domańska K; Zieliński R; Kubiński K; Sajnaga E; Masłyk M; Bretner M; Szyszka R
    Acta Biochim Pol; 2005; 52(4):947-51. PubMed ID: 16265593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular regulators of protein kinase CK2.
    Montenarh M
    Cell Tissue Res; 2010 Nov; 342(2):139-46. PubMed ID: 20976471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole.
    Battistutta R; Mazzorana M; Sarno S; Kazimierczuk Z; Zanotti G; Pinna LA
    Chem Biol; 2005 Nov; 12(11):1211-9. PubMed ID: 16298300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Casein kinase II inhibition induces apoptosis in pancreatic cancer cells.
    Hamacher R; Saur D; Fritsch R; Reichert M; Schmid RM; Schneider G
    Oncol Rep; 2007 Sep; 18(3):695-701. PubMed ID: 17671722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Casein kinase activity in etiolated Cucumis sativus cotyledons.
    Vidal D; Alvarez-Flórez F; Simón E
    Plant Biol (Stuttg); 2010 Jan; 12(1):134-44. PubMed ID: 20653896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.